Natixis Investment Managers International’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
OCBV
Natixis Investment Managers International's RMD Position: Q3 2022 in Review
Natixis Investment Managers International sold out of ResMed (RMD) in Q3 2022, closing a stake of 4,767 shares — an estimated $999K sold.
Natixis Investment Managers International first reported a position in RMD in Q4 2014 and held it in 8 quarters. The position peaked at $1.12M in Q3 2018. 668 funds tracked by Wall St. Rank hold RMD as of Q3 2022.
- Natixis Investment Managers International reported no remaining ResMed position as of Q3 2022 after selling out during the quarter.
- Natixis Investment Managers International sold 4,767 ResMed shares in Q3 2022, an estimated $999K.
- Natixis Investment Managers International first reported a position in ResMed in Q4 2014 and held it in 8 quarters.
- Natixis Investment Managers International's ResMed position peaked at $1.12M in Q3 2018.
- 668 funds tracked by Wall St. Rank held ResMed as of Q3 2022.
Based on Natixis Investment Managers International's 13F filing for Q3 2022, filed 14 Nov 2022.